In new draft guid­ance for man­u­fac­tur­ing in­spec­tions, FDA draws in­spi­ra­tion from pan­dem­ic meth­ods

The FDA pub­lished new man­u­fac­tur­ing guide­lines on Wednes­day de­tail­ing “al­ter­na­tive tools” to as­sess drug man­u­fac­tur­ing fa­cil­i­ties in pend­ing ap­pli­ca­tions.

The guid­ance …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER